American Association for the Advancement of Science, Science Translational Medicine, 624(13), 2021
DOI: 10.1126/scitranslmed.abk2267
Export citation
Search in Google Scholar
Show less
Full text: Unavailable
Targeting SBPTN1 with siRNA has the potential to treat NASH and prevent HCC.